Ci Balanced Income Asset Allocation Fund Series F Nl (CBJRX) Share Price

huge buy at 7:55 - 8:00

I agree with your assessment. Partnership news and PR from only NWBO (and not big pharma) without any cash injection will not lead to any appreciation in share price. The share price wont touch $1 in such a scenario. In fact, markets and shorts will sell the news and the share price will be back clo

$AGYP Natural Gas Sales Agreement to Power Crypto and Bitcoin Mining

https://www.stocktitan.net/news/AGYP/allied-energy-fuels-the-future-of-crypto-with-groundbreaking-natural-bty677tw2zg1.html

$AGYP Natural Gas Sales Agreement to Power Crypto and Bitcoin Mining

https://www.stocktitan.net/news/AGYP/allied-energy-fuels-the-future-of-crypto-with-groundbreaking-natural-bty677tw2zg1.html

$$ TPTW #1 on Breakout Boards ,Set to fly 70,000,000 shares traded yesterday .0002 !

@timodc

"The Army and other service branches are abandoning recruiting efforts at a prestigious Black engineering event this week...{citing} concerns that participation in the predominantly Black event could run afoul of Trump's orders"

you're an absolute nut case.

$$ TPTW #1 on Breakout Boards ,Set to fly 70,000,000 shares traded yesterday .0002 !

If you look at it this way you’re right. Still that won’t get us any richer.
Patrik

Show me another OTC ticker that has $40 million in rev's and projecting $85 million in 2025. $$$$$$ Weeeeeeeeeee

Senate Democrats Gear Up for a Whistleblower War Against Trump

Chuck Schumer invites government employees to anonymously tattle on the administration.

by Graham J Noble | Feb 11, 2025

Mr. Schumer and his colleagues have chosen to resist any effort to expo

Senate Democrats Gear Up for a Whistleblower War Against Trump

Chuck Schumer invites government employees to anonymously tattle on the administration.

by Graham J Noble | Feb 11, 2025

Mr. Schumer and his colleagues have chosen to resist any effort to expo

ASII should already be trading between .015-.02, and with $85 million, that easily puts us at .03-.05! Let’s go ASII😎💰

Hahahahahah 🛌 🛏️

----------
At minimum there should be mods here to stop that behavior

$AGYP Natural Gas Sales Agreement to Power Crypto and Bitcoin Mining

https://www.stocktitan.net/news/AGYP/allied-energy-fuels-the-future-of-crypto-with-groundbreaking-natural-bty677tw2zg1.html

Hard to say exactly what it means. Different holders may have different reasons for converting to common shares.
Here are some possibilities:
1) Preferred shareholders may want to convert to common shares in order to sell the commons for a profit at any price above $.02. Any sale below

......SERGIO P. ERMOTTI is nervous.......FRANK B. HOLDING, Jr. is nervous.................UWBI sewer rats, are AGLOW, with SACKS TINGLING.........

....btw, FCNCA.....needs to call HOUSTON, 'cause it has a problem....???.....

...First Citizens BancShares, Inc. (FCNCA)...

Get ready

Well that stings. Hopefully this does something. I'm right there with you since 2017 minus the warrants. If you can actually exercise any warrants you are ok anyway.

Well, you gotta love the spin the CEO out on the pr.

Argentum "acquires" whatever Biopharma instead of whatever Biopharma buys out Argentum. ...which would likely be much closer to actual reality.

I'm leaving my humble position alone for the time being to see if the inc

Wallnut you know what side of the trade I am and how long I have been here. NOTHING said on this board affects PPS movement. Upward momentum when people OUTSIDE of this board take notice and start buying. SC8 is not worth the oxygen it is that simple. Let the facts speak for themselves and they will

re KIT competition - THRD phase 1 data

https://ir.thirdharmonicbio.com/news-releases/news-release-details/third-harmonic-bio-announces-third-quarter-2024-financial

THRD is down over 30% premarket on this news. One LFT AE at highest dose, more pronounced anemia, only get

Gary, Fusion Pharmaceuticals (clinical stage phase 2 - prostrate cancer) was acquired by Merck in 2024 for $2.4 B (2 billion upfront):

Fusion Pharmaceuticals, March 2024, $2.4B: AstraZeneca acquired Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company specializing in n

I agree but you have to admit the concern is legitimate.